Trial intelligence / Profile preview

LGG in pediatric acute gastroenteritis

NCT01773967Phase 3Completed

Sponsor
Washington University School of Medicine
Start
Jul 2014
Primary completion
Aug 2018
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 3 trial of Lactobacillus rhamnosus GG in gastroenteritis, sponsored by Washington University School of Medicine. Started Jul 2014; status: completed.

02

Drugs

Lactobacillus rhamnosus GG
03

Conditions

gastroenteritis

Beyond the preview

Go deeper on NCT01773967.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01773967.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call